A national internet-linked based database for pediatric interstitial lung diseases: the French network

作者：Nathan Nadia^*; Abou Taam Rola; Epaud Ralph; Delacourt Christophe; Deschildre Antoine; Reix Philippe; Chiron Raphael; de Pontbriand Ulrika; Brouard Jacques; Fayon Michael; Dubus Jean Christophe; Giovannini Chami Lisa; Bremont Francois; Bessaci Katia; Schweitzer Cyril; Dalphin Marie Laure; Marguet Christophe; Houdouin Veronique; Troussier Francoise; Sardet Anne; Hullo Eglantine; Gibertini Isabelle; Mahloul Malika; Michon Delphine; Priouzeau Adrien; Galeron Laurie

来源：Orphanet Journal of Rare Diseases, 2012, 7(1): 40.

DOI：10.1186/1750-1172-7-40

• Interstitial lung disease
• Network
• Epidemiology
• Database

Background: Interstitial lung diseases (ILDs) in children represent a heterogeneous group of rare respiratory disorders that affect the lung parenchyma. After the launch of the French Reference Centre for Rare Lung Diseases (RespiRare (R)), we created a national network and a web-linked database to collect data on pediatric ILD. %26lt;br%26gt;Methods: Since 2008, the database has been set up in all RespiRare (R) centres. After patient%26apos;s parents%26apos; oral consent is obtained, physicians enter the data of children with ILD: identity, social data and environmental data; specific aetiological diagnosis of the ILD if known, genetics, patient visits to the centre, and all medical examinations and tests done for the diagnosis and/or during follow up. Each participating centre has a free access to his own patients%26apos; data only, and cross-centre studies require mutual agreement. Physicians may use the system as a daily aid for patient care through a web-linked medical file, backed on this database. %26lt;br%26gt;Results: Data was collected for 205 cases of ILD. The M/F sex ratio was 0.9. Median age at diagnosis was 1.5 years old [0-16.9]. A specific aetiology was identified in 149 (72.7%) patients while 56 (27.3%) cases remain undiagnosed. Surfactant deficiencies and alveolar proteinosis, haemosiderosis, and sarcoidosis represent almost half of the diagnoses. Median length of follow-up is 2.9 years [0-17.2]. %26lt;br%26gt;Conclusions: We introduce here the French network and the largest national database in pediatric ILDs. The diagnosis spectrum and the estimated incidence are consistent with other European databases. An important challenge will be to reduce the proportion of unclassified ILDs by a standardized diagnosis work-up. This database is a great opportunity to improve patient care and disease pathogenesis knowledge. A European network including physicians and European foundations is now emerging with the initial aim of devising a simplified European database/register as a first step to larger European studies.

• 出版日期2012-6-15